Gabapentin activates presynaptic GABAB heteroreceptors in rat cortical slices

European Journal of Pharmacology

Volumn 495, Issue 2-3, 2004, Pages 137-143

  Parker, David A S ^a   Ong, Jennifer ^a   Marino, Victor ^a   Kerr, David I B ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Baclofen; GABA; Gabapentin

Indexed keywords

(3 AMINO 2 HYDROXYPROPYL)METHYLPHOSPHINIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 5,5 DIMETHYL 2 MORPHOLINEACETIC ACID; BACLOFEN; CGP 44532; CGP 54626; GABAPENTIN; GLUTAMIC ACID; N 3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL 4 (CYCLOHEXYLMETHYL)PHOSPHINIC ACID; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN TISSUE; CONTROLLED STUDY; DRUG MECHANISM; ELECTROSTIMULATION; MALE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY;

AMINES; ANIMALS; BACLOFEN; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; MORPHOLINES; NEOCORTEX; ORGANOPHOSPHORUS COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; RECEPTORS, PRESYNAPTIC; TRITIUM;

EID: 3042841014     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.05.029     Document Type: Article

References (31)

1. Bertrand S., Ng Y.K., Purisai M.G., Wolfe S.E., Severidt M.W., Nouel D., Robitaille R., Low M.J., O'Neill G.P., Metters K., Lacaille J.C., Chronwall B.M., Morris S.J. The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain γ-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels. J. Pharmacol. Exp. Ther. 298:2001;15-24
2. B receptors in hippocampal pyramidal cells. Synapse. 50:2003;95-109
3. B receptors: first of the functional metabotropic heterodimers. J. Pharmacol. Exp. Ther. 292:2000;2-7
4. Bryans J.S., Davies N., Gee N.S., Horwell D.C., Kneen C.O., Morrell A.I., O'Neill J.A., Ratcliffe G.S. Investigation into the preferred conformation of gabapentin for interaction with its binding site on the α2δ subunit of a calcium channel. Bioorg. Med. Chem. Lett. 7:1997;2481-2484
5. +-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci. Lett. 280:2000;107-110
6. Field M.J., Oles R.J., Lewis A.S., McCleary S., Hughes J., Singh L. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesia agents. Br. J. Pharmacol. 121:1997;1513-1522
7. 1 receptor antagonist CI-1021 act synergistically in two rat models of neuropathic pain. J. Pharmacol. Exp. Ther. 303:2002;730-735
8. B agonists. J. Med. Chem. 38:1995;3297-3312
9. B receptor antagonists. Pharmacol. Rev. Commun. 8:1996;127-133
10. Gee N.S., Brown J.P., Dissanayake V.U.K., Offord J., Thurlow R., Woodruff G.N. The novel anticonvulsant drug, gabapentin (neurontin), binds to the α2δ subunit of a calcium channel. J. Biol. Chem. 271:1996;5768-5776
11. 3H]gabapentin to a novel site in rat brain: autoradiographic studies. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 244:1993;303-309
12. Hwang J.H., Yaksh T.L. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic model in the rat. Reg. Anesth. 22:1997;249-256
13. Jensen A.A., Mosbacher J., Elg S., Lingenhoehl K., Lohmann T., Johansen T.N., Abrahamsen B., Mattsson J.P., Lehmann A., Bettler B., Brauner-Osborne H. The anticonvulsant gabapentin (neurontin) does not act through γ-aminobutyric acid-B receptors. Mol. Pharmacol. 61:2002;1377-1384
14. B receptors: new challenges in drug design. Curr. Med. Chem. CNS Agents. 1:2001;27-42
15. B receptors by L-amino-acids and dipeptides in rat neocortex. Eur. J. Pharmacol. 468:2003;103-108
16. B receptor agonist. Neuropharmacology. 41:2001;965-975
17. B receptors and the effects of baclofen in the mammalian central nervous system. Prog. Neurobiol. 46:1995;423-462
18. Moore K.A., Baba H., Woolf C.J. Gabapentin - actions on adult superficial dorsal horn neurons. Neuropharmacology. 43:2002;1077-1081
19. Ng G.Y.K., Bertrand S., Sullivan R., Ethier N., Wang J., Yergey J., Belley M., Trimble L., Bateman K., Alder L., Smith A., Mckernan R., Metters K., O'Neill G.P., Lacaille J.-C., Hebert T.E. γ-Aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol. Pharmacol. 59:2001;144-152
20. Ong J., Kerr D.I.B., Johnston G.A.R., Hall R.G. Differing actions of baclofen and 3-aminopropylphosphinic acid in rat neocortical slices. Neurosci. Lett. 109:1990;169-173
21. B receptor antagonist in rat neocortical slices. Eur. J. Pharmacol. 362:1998;35-41
22. B receptor agonists CGP 44532 and CGP 44533 in central and peripheral preparations. Eur. J. Pharmacol. 412:2001;27-37
23. Rock D.M., Kelly K.M., Macdonald R.L. Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Res. 16:1993;89-98
24. Satzinger G. Antiepileptics from gamma-aminobutyric acid. Arzneimittelforschung. 44:1994;261-266
25. Shimoyama N., Shimoyama M., Davis A.M., Inturrisi C.E., Elliott K.J. Spinal gabapentin is antinociceptive in the rat formalin test. Neurosci. Lett. 222:1997;65-67
26. Stefani A., Spadoni F., Bernardi G. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology. 37:1997;83-91
27. Taylor C.P. Emerging perspectives on the mechanism of action of gabapentin. Neurology. 44:1994;S10-S16
28. Taylor C.P. Gabapentin: mechanisms of action. Levy R.H., Mattson R.H., Meldrum B.S. Antiepileptic Drugs. 1995;829-841 Raven Press, New York
29. Taylor C.P., Gee N.S., Su T.-Z., Kocsis J.D., Welty D.F., Brown J.P., Dooley D.J., Boden P., Singh L. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29:1998;233-249
30. B receptors as potential therapeutic targets. Curr. Drug Target CNS Neurol. Disord. 2:2003;248-259
31. 2+ influx and synaptic transmission in rat hippocampus and neocortex. Eur. J. Pharmacol. 449:2002;221-228